← 홈

Antibody · IBD (크론·대장)

71개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 71개
AntibodystaleJanssenApproved

ustekinumab (Stelara, 1: vedolizumab 2: infliximab 3: filgotinib 4: ustekinumab)

Ulcerative Colitis (UC) · Ulcerative Colitis (UC)

#UlcerativeColitisUC#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleAbbViePreclinical

Alvotech Biosimilar to Adalimumab (AVT02, AVT02 (Alvotech Biosimilar to Adalimumab))

Crohn Disease; Ulcerative Colitis · Crohn Disease

#CrohnDisease#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleAbbViePhase 3

adalimumab (Humira, Adalimumab PRN)

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleAbbViePreclinical

adalimumab (Humira, Adalimumab and Infliximab)

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAbbViePhase 2

adalimumab (Humira, Adalimumab-680LT)

Crohn Disease; Ulcerative Colitis · Crohn Disease

#CrohnDisease#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodyAbbViePhase 2

adalimumab (Humira, Adalimumab-800CW)

IBD; Rheumatoid Arthritis · IBD

#IBD#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodyChinese Medical AssociationApproved

Akkermansia muciniphila + Infliximab (Akkermansia muciniphila + Infliximab)

Crohn's Diseases · Crohn's Diseases

#CrohnsDiseases#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleJanssenApproved

Infusion (Anti-TNF: Infliximab, Anti-TNF: Infliximab (Infusion))

Crohn's Disease; Inflammatory Bowel Disease · Crohn's Disease

#CrohnsDisease#Antibody#Approved#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleAbbVieApproved

Subcutaneus (Anti-TNF:Adalimumab, Anti-TNF:Adalimumab (Subcutaneus))

Crohn's Disease; Inflammatory Bowel Disease · Crohn's Disease

#CrohnsDisease#Antibody#Approved#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleAbbViePreclinical

adalimumab (Humira, Application of Adalimumab)

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleAstraZenecaPhase 3

Brazikumab high dose (Brazikumab high dose)

Crohn's Disease; IBD · Crohn's Disease

#CrohnsDisease#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleAstraZenecaPhase 3

Brazikumab low dose (Brazikumab low dose)

Crohn's Disease; IBD · Crohn's Disease

#CrohnsDisease#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenApproved

CYCLOSPORINE VS INFLIXIMAB (CYCLOSPORINE VS INFLIXIMAB)

Ulcerative Colitis; Steroid Refractory · FRα

#FR#Antibody#Approved#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleFundación de Investigación Biom…Preclinical

ustekinumab (Stelara, Ex-vivo stimulation of cells with infliximab, golimumab, adalimumab, vedolizumab and ustekinumab)

Inflammatory Bowel Disease · Inflammatory Bowel Disease

#InflammatoryBowelDisease#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAbbViePhase 2

adalimumab (Humira, FITC-Adalimumab)

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 3

IFX alone (Infliximab, Infliximab (IFX alone))

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 3

IFX (Infliximab, Infliximab (IFX))

Ulcerative Colitis · Ulcerative Colitis

#UlcerativeColitis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenApproved

adalimumab (Humira, Infliximab Adalimumab y Golimumab)

Ulcerative Colitis; Thromboembolism · Ulcerative Colitis

#UlcerativeColitis#Antibody#Approved#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleJanssenApproved

Infliximab CT-P13 (Infliximab CT-P13)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenApproved

Infliximab Dose Intensification (Infliximab Dose Intensification)

Crohn Disease (CD) · Crohn Disease (CD)

#CrohnDiseaseCD#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING

2 / 4 페이지

← 이전다음 →